Immunogenic peptides derived from sclerostin
View Patent ↗Compositions and methods relating to antibodies that specifically bind to TGF-beta binding proteins are provided. These methods and compositions relate to altering bone mineral density by interfering with the interaction between a TGF-beta binding protein sclerostin and a TGF-beta superfamily member, particularly a bone morphogenic protein. Increasing bone mineral density has uses in diseases and conditions in which low bone mineral density typifies the condition, such as osteopenia, osteoporosis, and bone fractures.
1. An immunogen comprising a peptide of no more than 75 consecutive amino acids of a SOST polypeptide of SEQ ID NO: 1, 20, 58, 60, 62 or 68, said peptide comprising at least 4 consecutive amino acids of an amino acid sequence selected from the group consisting of SEQ ID NOs: 29, 30, 31, 32, 53, and 54, wherein the peptide is capable of eliciting an antibody that binds specifically to the SOST polypeptide.
2. The immunogen of claim 1 comprising a peptide of no more than 50 consecutive amino acids of a SOST polypeptide.
3. The immunogen of claim 1 , wherein the peptide comprises at least 6 consecutive amino acids of a SOST polypeptide of SEQ ID NO: 1, 58, 60, or 62.
4. The immunogen of claim 3 , wherein the peptide comprises at least 12 consecutive amino acids of a SOST polypeptide SEQ ID NO: 1, 58, 60, or 62.
5. The immunogen of claim 4 , wherein the peptide comprises at least 20 consecutive amino acids of a SOST polypeptide of SEQ ID NO: 1, 58, 60, or 62.
6. An immunogen comprising a peptide, wherein the peptide is a fragment of an amino acid sequence selected from the group consisting of SEQ ID NOs: 29, 30, 31, 32, 53, and 54, wherein the peptide comprises at least 4 consecutive amino acids of the amino acid sequence, and wherein the peptide is capable of eliciting an antibody that binds specifically to the SOST polypeptide.
7. An immunogen comprising a peptide, wherein the peptide is a fragment of SEQ ID NO: 53 comprising at least 4 consecutive amino acids of SEQ ID NO: 53, and wherein the peptide is capable of eliciting an antibody that binds specifically to the SOST polypeptide.
8. The immunogen of claim 7 , wherein the peptide comprises at least 6 consecutive amino acids of a SOST polypeptide of SEQ ID NO: 1.
9. The immunogen of claim 8 , wherein the peptide comprises at least 12 consecutive amino acids of a SOST polypeptide of SEQ ID NO: 1.
10. The immunogen of claim 9 , wherein the peptide comprises at least 20 consecutive amino acids of a SOST polypeptide of SEQ ID NO: 1, 58, 60, or 62.
11. The immunogen of claim 6 or claim 7 , wherein the peptide is associated with a carrier molecule.
12. The immunogen of claim 11 wherein the carrier polypeptide is keyhole limpet hemocyanin.
13. A method for producing an antibody that specifically binds to a SOST polypeptide, comprising immunizing an animal with an immunogen according to claim 6 or claim 7 .
14. An antibody produced by the method of claim 13 that is capable of increasing bone density in a mammal.
15. The antibody of claim 14 , wherein the antibody is a monoclonal antibody.
16. The antibody of claim 13 wherein the antibody is a humanized antibody or a chimeric antibody.
17. The antibody of claim 13 that comprises a single chain antibody.
18. An antigen-binding fragment of the antibody of claim 14 .
19. The antigen-binding fragment claim 18 , wherein the antigen-binding fragment is selected from the group consisting of F(ab′) 2 , Fab′, Fab, Fd, and Fv.
20. A composition comprising the antibody of claim 14 or an antigen-binding fragment thereof and a physiologically acceptable carrier.